nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Case Series of Lengthy Progression-Free Survival With Pemetrexed-Containing Therapy in Metastatic Non–Small-Cell Lung Cancer Patients Harboring ROS1 Gene Rearrangements
|
Riess, Jonathan W. |
|
2013 |
14 |
5 |
p. 592-595 4 p. |
artikel |
2 |
Analysis of Intratumor Heterogeneity of EGFR Mutations in Mixed Type Lung Adenocarcinoma
|
Tomonaga, Nanae |
|
2013 |
14 |
5 |
p. 521-526 6 p. |
artikel |
3 |
Crizotinib in the Treatment of Non–Small-Cell Lung Cancer
|
Rothschild, Sacha I. |
|
2013 |
14 |
5 |
p. 473-480 8 p. |
artikel |
4 |
Determinants of Survival in Advanced Non–Small-Cell Lung Cancer in the Era of Targeted Therapies
|
Bauml, Joshua |
|
2013 |
14 |
5 |
p. 581-591 11 p. |
artikel |
5 |
Editorial Board
|
|
|
2013 |
14 |
5 |
p. A1- 1 p. |
artikel |
6 |
ERCC1, MLH1, MSH2, MSH6, and βIII-Tubulin: Resistance Proteins Associated With Response and Outcome to Platinum-based Chemotherapy in Malignant Pleural Mesothelioma
|
Ting, Saskia |
|
2013 |
14 |
5 |
p. 558-567.e3 566443 p. |
artikel |
7 |
Molecularly Targeted Therapies in Locally Advanced Non–Small-Cell Lung Cancer
|
Devarakonda, Siddhartha |
|
2013 |
14 |
5 |
p. 467-472 6 p. |
artikel |
8 |
Multiplex PCR-Based Detection of Circulating Tumor Cells in Lung Cancer Patients Using CK19, PTHrP, and LUNX Specific Primers
|
Katseli, Anastasia |
|
2013 |
14 |
5 |
p. 513-520 8 p. |
artikel |
9 |
Patients Treated With Platinum-Doublet Chemotherapy for Advanced Non–Small-Cell Lung Cancer Have Inferior Outcomes If Previously Treated With Platinum-based Chemoradiation
|
Paramanathan, Ashvin |
|
2013 |
14 |
5 |
p. 508-512 5 p. |
artikel |
10 |
Phase II Study of Topotecan and Bevacizumab in Advanced, Refractory Non–Small-Cell Lung Cancer
|
Powell, Steven F. |
|
2013 |
14 |
5 |
p. 495-501 7 p. |
artikel |
11 |
Physicians' Knowledge and Practice of Lung Cancer Screening: A Cross-Sectional Survey Comparing General Practitioners, Thoracic Oncologists, and Pulmonologists in France
|
Couraud, Sébastien |
|
2013 |
14 |
5 |
p. 574-580 7 p. |
artikel |
12 |
Polymorphisms of CYP2D6 Gene and Gefitinib-Induced Hepatotoxicity
|
Takimoto, Takayuki |
|
2013 |
14 |
5 |
p. 502-507 6 p. |
artikel |
13 |
Prediction of Acute Toxicity Grade ≥ 3 in Patients With Locally Advanced Non–Small-Cell Lung Cancer Receiving Intensity Modulated Radiotherapy and Concurrent Low-Dose Cisplatin
|
Uyterlinde, Wilma |
|
2013 |
14 |
5 |
p. 541-548 8 p. |
artikel |
14 |
Predictive Value of Primary Fluorine-18 Fluorodeoxyglucose Standard Uptake Value for a Better Choice of Systematic Nodal Dissection or Sampling in Clinical Stage IA Non–Small-Cell Lung Cancer
|
Li, Xiaolin |
|
2013 |
14 |
5 |
p. 568-573 6 p. |
artikel |
15 |
Preoperative Chemotherapy Is Effective for Stage III Resectable Non–Small-Cell Lung Cancer: Metaanalysis of 16 Trials
|
Horita, Nobuyuki |
|
2013 |
14 |
5 |
p. 488-494 7 p. |
artikel |
16 |
19q13-ERCC1 Gene Copy Number Increase in Non–Small-Cell Lung Cancer
|
Vanhecke, Elsa |
|
2013 |
14 |
5 |
p. 549-557 9 p. |
artikel |
17 |
Rationale and Design of the Japan Molecular Epidemiology for Lung Cancer Study
|
Kawaguchi, Tomoya |
|
2013 |
14 |
5 |
p. 596-600 5 p. |
artikel |
18 |
Table of Contents
|
|
|
2013 |
14 |
5 |
p. A7-A10 nvt p. |
artikel |
19 |
The Differences of Biological Behavior Based on the Clinicopathological Data Between Resectable Large-Cell Neuroendocrine Carcinoma and Small-Cell Lung Carcinoma
|
Kinoshita, Tomonari |
|
2013 |
14 |
5 |
p. 535-540 6 p. |
artikel |
20 |
The Effect of a Lung Cancer Care Coordination Program on Timeliness of Care
|
Alsamarai, Susan |
|
2013 |
14 |
5 |
p. 527-534 8 p. |
artikel |
21 |
Toxicity of Concurrent Radiochemotherapy for Locally Advanced Non–Small-Cell Lung Cancer: A Systematic Review of the Literature
|
Koning, Caro C. |
|
2013 |
14 |
5 |
p. 481-487 7 p. |
artikel |